20191022 – Transgene PR Jefferies EN
Month: October 2019
First efficacy results of TG4001+avelumab in HPV16-positive cancers
https://channel.royalcast.com/webcast/transgene/20191003_1/
TG4001 + Avelumab Phase 1b results in HPV16+ R/M cancers
TG4001 + Avelumab Phase 1b/2 results in HPV16+ R/M cancers Detailed data of the Phase 1b/2 trial presented at SITC 2020 Read the poster Access the webcast November 2020